Cybersecurity is now a key factor in the approval process
IEC 81001-5-1 is already considered the state of the art, and Notified Bodies as well as the FDA now reject submissions solely on the grounds of inadequate cybersecurity.
We consistently integrate cybersecurity into development and quality management, ensuring that practical, regulatory-compliant processes are established throughout the product life cycle. We transform known requirements into verifiable work packages, clear responsibilities, and traceable evidence—based on risk rather than hasty activism.
Metecon integrates cybersecurity into your processes in a way that ensures security requirements remain feasible in day-to-day development and that documentation is generated in a traceable manner. We translate regulatory and normative requirements into clear work packages, responsibilities, and documentation structures—tailored to the product, risk, and maturity level—and prioritize measures with a risk-based approach across usage, architecture, maintenance, and the life cycle. In this way, cybersecurity becomes part of a consistent development and life cycle process rather than an isolated, additional task.
Intended for: Heads of Software Development / Heads of R&D and Heads of Regulatory Affairs / RA Managers, as well as executives at smaller manufacturers and Quality Management Representatives.
Cybersecurity requirements are known, but they have not been translated into concrete, verifiable work packages. This leads to frantic, reactive action.
Development, RA, QM, and the cybersecurity team work independently of each other. Documentation remains contradictory or incomplete.
Risk, security measures, testing, and operational processes are not integrated. This leads to follow-up inquiries and additional work.
IEC 81001-5-1 is already considered the state of the art, and Notified Bodies as well as the FDA now reject submissions solely on the grounds of inadequate cybersecurity.
The EU and the FDA have some requirements in common, but differ in certain details. We integrate both sets of requirements into a consistent documentation framework.
The general safety requirements (MDR/IVDR Annex I, including Section 17.2 on cybersecurity) are specified in detail by Guideline MDCG 2019-16.
The EU sets the requirements through the MDR/IVDR regulatory framework. Implementation is carried out through standards such as IEC 81001-5-1.
Clearly break down the safety requirements from the MDR/IVDR to apply them to your product and incorporate them into your safety concept.
Cybersecurity as a design principle rather than an afterthought, throughout the entire life cycle
Prepare consistent evidence of information security and present it in a robust manner during discussions with the Notified Body.
The FDA requires an SBOM that complies with NTIA specifications, including end-of-support information for each component, architectural views, and metrics on vulnerability response capabilities. “Cyber device” refers to all data interfaces, including USB.
Software bill of materials, including end-of-support for each item. Precise, as required by the FDA.
Presenting safety-related architecture in a transparent manner—a key focus of the FDA.
Measure and document responsiveness to vulnerabilities.
IEC 81001-5-1 is the process standard for cybersecurity in the software life cycle and supplements IEC 62304/IEC 82304-1. For cybersecurity in risk management, AAMI TIR57 supplements traditional risk management according to ISO 14971 with security activities.
Security activities by life cycle phase – the process standard as the backbone of the verification framework.
Risk management supplemented by cybersecurity.
We develop the right strategy for your product (including PMCF) and guide you from planning through implementation—ensuring regulatory compliance while minimizing the workload for your team.
Define security objectives, the threat model, and the security architecture early on—during the design and development phases.
Conduct threat modeling and security risk assessment (AAMI TIR57).
Translate security requirements into verifiable work packages and clear responsibilities.
The backbone of compliance: Plan security tests and penetration tests and consistently link them to requirements, risks, and releases. This ensures that it can be demonstrated at any time that every threat has been addressed and that the measures taken are effective.
Create a software bill of materials and consistently compile security documentation for submission (EU/FDA).
Monitor vulnerabilities, manage updates, and keep cybersecurity documentation up to date following changes.
We prioritize measures based on actual usage, architecture, and risk. This results in a practical approach to cybersecurity that effectively integrates development, changes, and regulatory requirements in a way that is manageable over the long term.
Documented threat model and other methods in accordance with AAMI TIR57. Provides information for risk management in accordance with ISO 14971.
7+ years of experience with SBOM and update reviews, including vulnerability and update management throughout the life cycle.
Test strategy and penetration tests are consistently linked to requirements and risks.
Secure development, change/configuration management, CAPA, and supplier control—all audit-ready within the QMS.
Identify and meet requirements once, then use them for both markets. With EU-vs-FDA mapping.
The benchmarks are based on the strengths of leading providers—the depth of specialized knowledge from expert institutions, security specialists' expertise in SBOM and threat modeling, and testing expertise. Metecon meets these criteria and integrates them into its MDSW product documentation through end-to-end process integration.
Cybersecurity (information security) is a component of software life cycle activities. We cover medical device software (MDSW), AI regulation, and software validation on separate pages—linked here as related product documentation.
Reviewing existing cybersecurity policies and identifying gaps in compliance with MDR/IVDR, MDCG 2019-16, and IEC 81001-5-1. Includes specific recommendations for action.
In-house training and workshops on cybersecurity requirements and processes for development, regulatory affairs, and quality management.
For SBOM creation, vulnerability scans, and penetration tests, we integrate specialized tools and partners as needed. Integrated into your compliance framework.
Preparation and coaching for cybersecurity, applicable to assessments, audits, and conformity assessment. Valid for use with Notified Bodies and the FDA.
The same approach applies under the IVDR to software in and as an IVD.
We start right where you are. With a GAP analysis, risk-based prioritization, and a clear roadmap to a consistent cybersecurity compliance framework.
Assess and track cybersecurity risks in a manner consistent with product risk management (ISO 14971).
Integrate safety analyses and the safety concept into the product documentation.
Penetration testing and verification reports with clear traceability.
Ensure cybersecurity at the process level and firmly establish change/configuration management, CAPA, and supplier controls in a manner that stands up to audits.
Cybersecurity as part of the software life cycle. From requirements to maintenance.
AI-based systems require robust cybersecurity strategies throughout their entire life cycle.

As a Principal Expert in Software & AI and as a RAC Devices specialist, Thorsten Stumpf is one of our top software experts and has an extensive network in the industry on this topic. Thorsten’s team supports manufacturers in the regulatory implementation of cybersecurity requirements for medical device software and integrates cybersecurity in a structured manner into development and risk management processes—not as an add-on, but as an integral part of the regulatory product architecture.
IEC 81001-5-1 • Threat Model & SBOM • EU & FDA"Cybersecurity rarely fails due to a lack of knowledge, but rather due to a lack of implementation: Regulatory requirements are not implemented—or are not implemented consistently—and the development, regulatory affairs, and quality management teams do not incorporate information security to the required extent. We embed information security in a risk-based manner within development and quality management: using threat models, SBOMs, and consistent evidence throughout the entire life cycle—and you avoid last-minute activism right before submission."
– Thorsten Stumpf · Principal Expert Software & AI · RAC Devices · Metecon
As early as possible—starting with the design and development phase, when the architecture and security concept are being developed, and no later than before submission. Only cybersecurity measures that are incorporated early on will result in a product that embodies “security by design.”
Through comprehensive documentation: Derive requirements from the threat model and risk assessment, validate them through verification and penetration tests, and keep them up to date via PMS even after release.
When a documented threat model is in place, security risks are linked to product risk management, measures derived from it have been tested and validated, and the corresponding evidence is kept up to date throughout the product’s life cycle. A lack of cybersecurity activities within the process landscape and isolated individual documents that merely highlight cybersecurity in isolation—without any impact on the product’s information security—are a warning sign.
Every change is evaluated for its impact on cybersecurity by updating the threat model or risk analysis. This makes it possible to assess whether new vulnerabilities arise, which tests need to be repeated, and how compliance can be consistently demonstrated.
Security risks must be integrated with product risk management (ISO 14971). The results of cybersecurity activities must be consistently integrated into product risk management. The measures derived from risk management must, in turn, feed back into cybersecurity activities, such as penetration tests. Risk management remains the central linchpin for medical devices. For networked products, the safety and performance of the products must be guaranteed as well at all times throughout their life cycle.
When requirements are known but cannot be met with in-house resources; when development, regulatory affairs, quality management, and IT security operate in silos, preventing the consistent implementation of information security; or when there are shortcomings in the documentation of cybersecurity tailored to the needs of the relevant target market. External support provides structure, documentation expertise, and a consistent approach.
The basis are the safety requirements set forth in Annex I of the MDR/IVDR (including 17.2 and 16.2), as well as guideline MDCG 2019-16.
The effort involved depends on the product, architecture, risk, and maturity level, as well as the target markets (EU/FDA). During a free initial consultation, we’ll assess your situation, prioritize based on risk, and then provide a robust framework.
Start with a free initial consultation. We prioritize based on risk, align EU and FDA requirements, and outline your security compliance framework.
Your contact:
Milan Weiß
Sales Manager
T: +49 621 123469-040
milan.weiss@metecon.de
